First Time Loading...

Livzon Pharmaceutical Group Inc
SZSE:000513

Watchlist Manager
Livzon Pharmaceutical Group Inc Logo
Livzon Pharmaceutical Group Inc
SZSE:000513
Watchlist
Price: 40.1 CNY 1.75% Market Closed
Updated: May 3, 2024

Livzon Pharmaceutical Group Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Livzon Pharmaceutical Group Inc
Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Livzon Pharmaceutical Group Inc
SZSE:000513
Revenue
¥12.4B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
10%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
¥10.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
¥9.7B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
¥22.3B
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
¥39.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
9%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Revenue
¥2.5B
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
N/A

See Also

What is Livzon Pharmaceutical Group Inc's Revenue?
Revenue
12.4B CNY

Based on the financial report for Dec 31, 2023, Livzon Pharmaceutical Group Inc's Revenue amounts to 12.4B CNY.

What is Livzon Pharmaceutical Group Inc's Revenue growth rate?
Revenue CAGR 10Y
10%

Over the last year, the Revenue growth was -2%. The average annual Revenue growth rates for Livzon Pharmaceutical Group Inc have been 6% over the past three years , 7% over the past five years , and 10% over the past ten years .